HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 625-636 of 1,979
Drug study icon
CompletedNCT00314184

Quetiapine Fumarate Bipolar Maintenance Monotherapy

What is this study about?

This study evaluated the safety and effectiveness of quetiapine fumarate for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
BipolarityMedication studyAges 18+
Countries
United States, Argentina, Bulgaria, + 12 others
Sponsor
AstraZeneca
Drug study icon
CompletedNCT00223249

Quetiapine in people with Bipolar and Alcohol Abuse/Dependence

Official study title

A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Alcohol Abuse/ Dependence.

This study has finished and is no longer accepting participants.

In Dallas
BipolarityMedication studyAges 18–70
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Drug study icon
CompletedNCT00428298

Research Study of Bipolar Mood Symptoms and Cognitive Problems

Official study title

A Double Blind Placebo Controlled Study of Valacyclovir in Cognitive Impairment and Mood Symptoms of Bipolar Disorder

This study has finished and is no longer accepting participants.

In Baltimore
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Johns Hopkins University
Other study type icon
CompletedNCT01503489

Risk Factors for AD-Associated Switch to Mania

Official study title

Risk for Antidepressant-associated Switch From Depression to Hypomania, Mania, or Mixed Episode During the 8 Weeks After the Introduction of an Antidepressant or After Increasing the Dosage of Baseline Antidepressant.

This study has finished and is no longer accepting participants.

In Barcelona
BipolarityObservational studyAges 18–80
Countries
Spain
Sponsor
Hospital Clinic of Barcelona
Behavioral study icon
CompletedNCT00499096

Self-Management Addressing Heart Disease Risk study

Official study title

Cardiovascular Risk Factors in Veterans With Bipolar Disorder

This study has finished and is no longer accepting participants.

In Ann Arbor
BipolarityBehavioural studyAges 18+
Countries
United States
Sponsor
US Department of Veterans Affairs
Drug study icon
CompletedNCT00097032

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

Official study title

Differences in Cognitive Function Due to Acute Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Out-Patients.

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 18–45
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT00501865

Effect of Food on the Concentration of GW273225 for Bipolarity

Official study title

An Open, Randomised, Two-period Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of GW273225 Administered Immediately After Food and Administered in Fasted State to Healthy Male and Female Subjects

This study has finished and is no longer accepting participants.

In Cambridge
BipolarityMedication studyAges 18–55
Countries
United Kingdom
Sponsor
GlaxoSmithKline
Drug study icon
CompletedNCT00259272

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Official study title

Phase IIIb, Multicenter, Single-Arm Open-Label Study, Supporting the Development and the Validation of the MATHYS Scale (Multidimensional Assessment of THYmic States) in a Population of Bipolar Patients Treated With Olanzapine, Either in-Label (Manic and Mixed Patients) and Off-Label (Hypomanic and Bipolar Depression)

This study has finished and is no longer accepting participants.

Multiple locations, including Andilly
BipolarityMedication studyAges 18+
Countries
France
Sponsor
Eli Lilly and Company
Behavioral study icon
CompletedNCT03266679

Psychological Factors In The Treatment Of Bipolar Mood Disorders

Official study title

Bipolar Mood Disorders: A Recovery-Oriented Intervention Approach Addressing Deficits In Metacognitive Capacities

This study has finished and is no longer accepting participants.

In Brisbane
BipolarityInterventional study
Countries
Australia
Sponsor
Queensland University of Technology

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.